Doxycycline Hyclate Patent Expiration
Doxycycline Hyclate is Used for treating or preventing infections caused by susceptible bacteria. It was first introduced by Pfizer Laboratories Div Pfizer Inc
Doxycycline Hyclate Patents
Given below is the list of patents protecting Doxycycline Hyclate, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Doryx Mpc | US9446057 | Controlled release doxycycline | Dec 23, 2034 | Mayne Pharma |
Doryx Mpc | US9295652 | Controlled release doxycycline | Oct 23, 2034 | Mayne Pharma |
Doryx Mpc | US9511031 | Controlled release doxycycline | Oct 23, 2034 | Mayne Pharma |
Doryx | US8715724 | Tabletting process | Feb 03, 2028 | Mayne Pharma |
Doryx Mpc | US8715724 | Tabletting process | Feb 03, 2028 | Mayne Pharma |
Doryx | US6958161 | Modified release coated drug preparation |
Dec 15, 2022
(Expired) | Mayne Pharma |
Doryx Mpc | US6958161 | Modified release coated drug preparation |
Dec 15, 2022
(Expired) | Mayne Pharma |
Doxycycline Hyclate's Family Patents

Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List